- Home
- ELWS vs GCTK Comparison
ELWS vs GCTK Comparison
Compare ELWS & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- GCTK
- Stock Information
- Founded
- ELWS 2018
- GCTK 2001
- Country
- ELWS Japan
- GCTK United States
- Employees
- ELWS N/A
- GCTK 6
- Industry
- ELWS
- GCTK Medical/Dental Instruments
- Sector
- ELWS
- GCTK Health Care
- Exchange
- ELWS Nasdaq
- GCTK Nasdaq
- Market Cap
- ELWS 6.2M
- GCTK 2.5M
- IPO Year
- ELWS 2023
- GCTK N/A
- Fundamental
- Price
- ELWS $1.89
- GCTK $0.17
- Analyst Decision
- ELWS
- GCTK
- Analyst Count
- ELWS 0
- GCTK 0
- Target Price
- ELWS N/A
- GCTK N/A
- AVG Volume (30 Days)
- ELWS 14.0K
- GCTK 8.9M
- Earning Date
- ELWS 03-03-2025
- GCTK 05-14-2025
- Dividend Yield
- ELWS N/A
- GCTK N/A
- EPS Growth
- ELWS N/A
- GCTK N/A
- EPS
- ELWS N/A
- GCTK N/A
- Revenue
- ELWS $2,292,406.00
- GCTK N/A
- Revenue This Year
- ELWS N/A
- GCTK N/A
- Revenue Next Year
- ELWS N/A
- GCTK N/A
- P/E Ratio
- ELWS N/A
- GCTK N/A
- Revenue Growth
- ELWS 404.13
- GCTK N/A
- 52 Week Low
- ELWS $1.04
- GCTK $0.16
- 52 Week High
- ELWS $8.68
- GCTK $99.00
- Technical
- Relative Strength Index (RSI)
- ELWS 43.93
- GCTK 28.31
- Support Level
- ELWS $2.00
- GCTK $0.16
- Resistance Level
- ELWS $2.34
- GCTK $0.24
- Average True Range (ATR)
- ELWS 0.26
- GCTK 0.06
- MACD
- ELWS 0.03
- GCTK 0.04
- Stochastic Oscillator
- ELWS 24.45
- GCTK 3.75
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an innovative long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.